PPD is a common perinatal complication experienced by one in eight women and has adverse maternal and infant outcomes. Zuranolone, developed by Sage Therapeutics and Biogen, is an oral, once-daily neuroactive steroid Pill used in a 14-day treatment course for patients with severe PPD. “In the trial, zuranolone demonstrated significant improvements in depressive symptoms and […]